Burcon Nutrascience Corporation
BU.TO
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.12% | -59.75% | -23.38% | 26.19% | -26.39% |
| Total Depreciation and Amortization | 42.82% | 113.32% | 166.28% | -6.86% | 11.69% |
| Total Amortization of Deferred Charges | 0.39% | 3.81% | -2.52% | -2.59% | 0.39% |
| Total Other Non-Cash Items | -25.69% | 152.65% | 24.33% | 9.42% | 52.03% |
| Change in Net Operating Assets | 83.95% | -556.97% | 179.85% | -165.41% | 219.21% |
| Cash from Operations | 26.31% | -172.72% | 31.80% | -18.84% | 35.08% |
| Capital Expenditure | -253.83% | -75.41% | -516.16% | 50.25% | 84.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -137.90% | 103.21% | -25,857.89% | -64.15% | -50.70% |
| Cash from Investing | -416.40% | 92.73% | -17,231.67% | 35.48% | 91.25% |
| Total Debt Issued | -- | -- | -78.50% | -- | -- |
| Total Debt Repaid | -32.76% | 97.35% | -3,801.79% | 47.66% | 75.51% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 63.12% | -2,712.20% | 200.00% | 62.56% |
| Cash from Financing | 90.86% | -100.96% | 794.28% | 927.69% | 245.51% |
| Foreign Exchange rate Adjustments | 117.69% | -8,156.25% | -85.96% | 208.57% | -166.88% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.25% | -147.24% | 1,561.99% | 61.40% | 44.48% |